ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $676,000 | -20.2% | 1,845,873 | +19.8% | 0.00% | 0.0% |
| Q1 2019 | $847,000 | +24.9% | 1,540,559 | +12.6% | 0.00% | 0.0% |
| Q4 2018 | $678,000 | -24.6% | 1,367,959 | +23.6% | 0.00% | 0.0% |
| Q3 2018 | $899,000 | -40.6% | 1,107,025 | +20.1% | 0.00% | 0.0% |
| Q2 2018 | $1,514,000 | +47.3% | 921,961 | +137.6% | 0.00% | 0.0% |
| Q1 2018 | $1,028,000 | +5.1% | 388,100 | +38.9% | 0.00% | 0.0% |
| Q4 2017 | $978,000 | +68.6% | 279,400 | +143.2% | 0.00% | 0.0% |
| Q3 2017 | $580,000 | +182.9% | 114,900 | +90.5% | 0.00% | – |
| Q2 2017 | $205,000 | +50.7% | 60,300 | +55.4% | 0.00% | – |
| Q1 2017 | $136,000 | +65.9% | 38,800 | +1.8% | 0.00% | – |
| Q4 2016 | $82,000 | -62.7% | 38,100 | -44.9% | 0.00% | – |
| Q3 2016 | $220,000 | – | 69,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |